Drug intelligence / Profile preview

clotrimazole + hydrocortisone acetate

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Topical
01

Overview

Clotrimazole + hydrocortisone acetate is a topical combination drug containing clotrimazole, an imidazole-class antifungal agent, and hydrocortisone acetate, a mild corticosteroid. Clotrimazole works by inhibiting lanosterol 14α-demethylase, which disrupts fungal cell membrane ergosterol biosynthesis, while hydrocortisone acetate targets glucocorticoid receptors to reduce inflammation, swelling, redness, and itching. This combination is primarily used to treat inflamed fungal skin infections, such as athlete's foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis), and tinea versicolor. Skinvisible is developing a proprietary formulation of clotrimazole 1% and hydrocortisone acetate 0.5% using its Invisicare polymer technology, which is designed to enhance topical delivery, provide sustained release, and improve skin adherence.

Brand names
Canesten ExtraCanesten HCCanesten PlusClotrizoneHydroagistenMycoten-HCZihyd-Plus
Other names
Clotrimazole 1% + Hydrocortisone Acetate 0.5%clotrimazole and hydrocortisone acetateclotrimazole/hydrocortisone acetatehydrocortisone acetate + clotrimazolehydrocortisone acetate and clotrimazolehydrocortisone acetate/clotrimazole
02

Targets

CYP51A1 (Sterol 14α-demethylase)CYP5218 (Cytochrome P450 5218)GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on clotrimazole + hydrocortisone acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clotrimazole + hydrocortisone acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call